Daljit Singh Aurora, Chief Strategy Officer at Neumora Therapeutics, Inc. (NMRA), sold 8,565 shares at $1.68 ($14K) on 2025-02-18, disclosed to the SEC on 2025-02-20.
Scheduled sale ($14k) by Chief Strategy Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| NMRA | SELL | 2026-02-19 | $22K | — | Filing → |
| NMRA | SELL | 2025-11-13 | $615K | — | Filing → |